
Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025
Description
Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on positron emission tomography (pet) nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for positron emission tomography (pet) nuclear medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) nuclear medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: F-18; Rb-82; Other Types
2) By Procedure: Diagnostic Procedures; Single Photon Emission Computed Tomography Procedures; Positron Emission Tomography Procedures; Therapeutic Procedures; Beta Emitter Procedures; Alpha Emitter Procedures; Brachytherapy Procedures
3) By Application: Oncology; Cardiology; Neurology; Other Applications
4) By End User: Hospitals; Diagnostic Centers; Research Institutes
Subsegments:
1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose); F-18 NaF (Sodium Fluoride); F-18 Fluorocholine
2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging; Rb-82 for Cardiac PET Stress Testing; Rb-82 for Other Cardiac Applications
3) By Other Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Ga-68 (Gallium-68)
Companies Mentioned: Cardinal Health; Bayer AG; Medtronic plc; Siemens Healthineers AG; Fujifilm Holdings Corporation; Stryker Corporation; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Agfa HealthCare NV; Scripps Health; Shimadzu Corporation; Jubilant DraxImage Inc.; Neusoft Medical Systems Co. Ltd.; Toshiba America Medical Systems Inc.; Lantheus Holdings Inc.; Advanced Accelerator Applications; Bruker Corporation; Eckert & Ziegler Strahlen- und Medizintechnik AG; Canon Medical Systems Corporation; Digirad Corporation; NorthStar Medical Radioisotopes LLC; Mediso Medical Imaging Systems Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on positron emission tomography (pet) nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for positron emission tomography (pet) nuclear medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) nuclear medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: F-18; Rb-82; Other Types
2) By Procedure: Diagnostic Procedures; Single Photon Emission Computed Tomography Procedures; Positron Emission Tomography Procedures; Therapeutic Procedures; Beta Emitter Procedures; Alpha Emitter Procedures; Brachytherapy Procedures
3) By Application: Oncology; Cardiology; Neurology; Other Applications
4) By End User: Hospitals; Diagnostic Centers; Research Institutes
Subsegments:
1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose); F-18 NaF (Sodium Fluoride); F-18 Fluorocholine
2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging; Rb-82 for Cardiac PET Stress Testing; Rb-82 for Other Cardiac Applications
3) By Other Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Ga-68 (Gallium-68)
Companies Mentioned: Cardinal Health; Bayer AG; Medtronic plc; Siemens Healthineers AG; Fujifilm Holdings Corporation; Stryker Corporation; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Agfa HealthCare NV; Scripps Health; Shimadzu Corporation; Jubilant DraxImage Inc.; Neusoft Medical Systems Co. Ltd.; Toshiba America Medical Systems Inc.; Lantheus Holdings Inc.; Advanced Accelerator Applications; Bruker Corporation; Eckert & Ziegler Strahlen- und Medizintechnik AG; Canon Medical Systems Corporation; Digirad Corporation; NorthStar Medical Radioisotopes LLC; Mediso Medical Imaging Systems Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Longevity And Anti-senescence Therapy Market Characteristics
- 3. Longevity And Anti-senescence Therapy Market Trends And Strategies
- 4. Longevity And Anti-senescence Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Longevity And Anti-senescence Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Longevity And Anti-senescence Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Longevity And Anti-senescence Therapy Market Growth Rate Analysis
- 5.4. Global Longevity And Anti-senescence Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Longevity And Anti-senescence Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Longevity And Anti-senescence Therapy Total Addressable Market (TAM)
- 6. Longevity And Anti-senescence Therapy Market Segmentation
- 6.1. Global Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Senolytic Drug Therapy
- Gene Therapy
- Cell Therapy
- Mitochondrial Therapy
- Immunotherapy
- Other Therapies
- 6.2. Global Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Longevity
- Senescence Inhibition
- Cardiovascular Diseases
- Neural Degenerative Diseases
- Ophthalmology Disorders
- Cancer
- 6.3. Global Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Medical Service Institution
- 6.4. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Senolytic Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecule Senolytics
- Natural Senolytics
- Combination Senolytic Treatments
- 6.5. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CRISPR-Based Gene Therapy
- Viral Vector Gene Therapy
- RNA Interference Therapy
- 6.6. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stem Cell Therapy
- Immune Cell Therapy
- Regenerative Cell Therapy
- 6.7. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Mitochondrial Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mitochondrial Replacement Therapy
- Mitochondrial Enhancement Compounds
- Mitochondrial Gene Therapy
- 6.8. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- Vaccines For Aging
- 6.9. Global Longevity And Anti-senescence Therapy Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormone Replacement Therapy
- Nutraceuticals And Dietary Supplements
- Lifestyle And Behavioral Interventions
- 7. Longevity And Anti-senescence Therapy Market Regional And Country Analysis
- 7.1. Global Longevity And Anti-senescence Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Longevity And Anti-senescence Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Longevity And Anti-senescence Therapy Market
- 8.1. Asia-Pacific Longevity And Anti-senescence Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Longevity And Anti-senescence Therapy Market
- 9.1. China Longevity And Anti-senescence Therapy Market Overview
- 9.2. China Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Longevity And Anti-senescence Therapy Market
- 10.1. India Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Longevity And Anti-senescence Therapy Market
- 11.1. Japan Longevity And Anti-senescence Therapy Market Overview
- 11.2. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Longevity And Anti-senescence Therapy Market
- 12.1. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Longevity And Anti-senescence Therapy Market
- 13.1. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Longevity And Anti-senescence Therapy Market
- 14.1. South Korea Longevity And Anti-senescence Therapy Market Overview
- 14.2. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Longevity And Anti-senescence Therapy Market
- 15.1. Western Europe Longevity And Anti-senescence Therapy Market Overview
- 15.2. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Longevity And Anti-senescence Therapy Market
- 16.1. UK Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Longevity And Anti-senescence Therapy Market
- 17.1. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Longevity And Anti-senescence Therapy Market
- 18.1. France Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Longevity And Anti-senescence Therapy Market
- 19.1. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Longevity And Anti-senescence Therapy Market
- 20.1. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Longevity And Anti-senescence Therapy Market
- 21.1. Eastern Europe Longevity And Anti-senescence Therapy Market Overview
- 21.2. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Longevity And Anti-senescence Therapy Market
- 22.1. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Longevity And Anti-senescence Therapy Market
- 23.1. North America Longevity And Anti-senescence Therapy Market Overview
- 23.2. North America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Longevity And Anti-senescence Therapy Market
- 24.1. USA Longevity And Anti-senescence Therapy Market Overview
- 24.2. USA Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Longevity And Anti-senescence Therapy Market
- 25.1. Canada Longevity And Anti-senescence Therapy Market Overview
- 25.2. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Longevity And Anti-senescence Therapy Market
- 26.1. South America Longevity And Anti-senescence Therapy Market Overview
- 26.2. South America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Longevity And Anti-senescence Therapy Market
- 27.1. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Longevity And Anti-senescence Therapy Market
- 28.1. Middle East Longevity And Anti-senescence Therapy Market Overview
- 28.2. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Longevity And Anti-senescence Therapy Market
- 29.1. Africa Longevity And Anti-senescence Therapy Market Overview
- 29.2. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Longevity And Anti-senescence Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Longevity And Anti-senescence Therapy Market Competitive Landscape And Company Profiles
- 30.1. Longevity And Anti-senescence Therapy Market Competitive Landscape
- 30.2. Longevity And Anti-senescence Therapy Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BioAge Labs Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Unity Biotechnology Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Insilico Medicine Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Human Longevity Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Longevity And Anti-senescence Therapy Market Other Major And Innovative Companies
- 31.1. Calico Life Sciences LLC
- 31.2. Recursion Pharmaceuticals
- 31.3. AgeX Therapeutics Inc.
- 31.4. Alkahest Inc.
- 31.5. CohBar Inc.
- 31.6. Stealth Bio Therapeutics
- 31.7. Altos Labs
- 31.8. Navitor Pharmaceuticals Inc.
- 31.9. Sierra Sciences LLC
- 31.10. T.A. Sciences Inc.
- 31.11. Juvenescence AI Limited
- 31.12. MDB Capital Holdings LLC
- 31.13. Senex Biotechnology
- 31.14. Spotlight Bioscience
- 31.15. Prana Biotechnology Ltd.
- 32. Global Longevity And Anti-senescence Therapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Longevity And Anti-senescence Therapy Market
- 34. Recent Developments In The Longevity And Anti-senescence Therapy Market
- 35. Longevity And Anti-senescence Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Longevity And Anti-senescence Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Longevity And Anti-senescence Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Longevity And Anti-senescence Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.